<乌鸦传媒>IBD Interferes With Sleep Quality Intestinal as well as brain-related problems found in study that used wrist actigraphy devices Jan 23, 2023
<乌鸦传媒>IBD and Rheumatic Diseases Overlap Specialists in both fields need to communicate and coordinate, says researcher Jan 23, 2023
<乌鸦传媒>Hyperbaric Oxygen Therapy Promising for Crohn's Fistulas Literature review highlights benefits, although access is an issue, expert says Jan 22, 2023
<乌鸦传媒>Patients With Celiac and Overlap IBD Skip Out on Gluten-Free Diets Study finds no appetite for long-term adherence; lack of targeted education Jan 22, 2023
<乌鸦传媒>Wearable Tech Shows Promise for Predicting IBD Flares App measured heart rate variability metrics in patients with Crohn's, ulcerative colitis Jan 21, 2023
<乌鸦传媒>Contrary to Guidelines, 5-ASA Often Prescribed in Pediatric Crohn's Disease Use at diagnosis associated with delays in starting biologics Jan 20, 2023
<乌鸦传媒>IBD Risk Higher After Antibiotics Dose-response relationship found, especially for older individuals Jan 09, 2023
<乌鸦传媒>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<乌鸦传媒>Small Study Shows Most Crohn's Patients With Anal Cancer Survived 15 of 24 were alive and cancer free at 5.5 years of follow-up Dec 09, 2022
<乌鸦传媒>Antibiotic Exposure Before Age 2 Tied to Increased Risk of Pediatric IBD Even exposure during the last trimester of pregnancy increases this risk, researchers say Dec 08, 2022
<乌鸦传媒>Do Kidney Transplant Medications Supplant IBD Drugs? Study shows many patients no longer need drugs to help keep gut disease in check Dec 08, 2022
<乌鸦传媒>Joint Pain Linked to Worse Quality of Life in Ulcerative Colitis Patients Pain tied to increased risks of depression, anxiety, fatigue, and social impairment Dec 08, 2022
<乌鸦传媒>COVID-19 Booster Vaccine Appears Safe for IBD Patients Third shot reactions mirror earlier primary doses, study showed Dec 07, 2022
<乌鸦传媒>Infliximab Maintenance Home Infusion Appears Safe Few serious adverse events occurred in patient-friendly settings Dec 07, 2022
<乌鸦传媒>Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<乌鸦传媒>Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitis Post-hoc analysis showed symptom relief as early as day 1 with the JAK inhibitor Dec 02, 2022
<乌鸦传媒>Nearly 1 in 7 Adults Experience Bloating on Any Given Week Some individuals report feeling uncomfortable discussing it with their doctors Nov 17, 2022
<乌鸦传媒>Pandemic's Impact on Liver Disease in the Spotlight at Liver Meeting A roundup of news from the AASLD annual meeting Nov 04, 2022
<乌鸦传媒>Continuing Ozanimod Prevented More Relapses in Ulcerative Colitis Disease control also maintained with temporary withdrawal, at least initially Oct 28, 2022
<乌鸦传媒>Upadacitinib Maintenance Triples Clinical Remissions in Crohn's Disease U-ENDURE trial also hit co-primary endpoint for endoscopic response Oct 27, 2022
<乌鸦传媒>Two More IBD Drugs Cleared for Safety During Pregnancy Ustekinumab, vedolizumab not linked to greater risk of complications Oct 26, 2022
<乌鸦传媒>Guselkumab-Golimumab Combo Shows Promise for Ulcerative Colitis More clinical remissions, endoscopic improvements, early trial finds Oct 26, 2022
<乌鸦传媒>Higher Upadacitinib Dose May Be Better for UC Maintenance Post-hoc analysis suggested less severe disease and longer remission over 1 year Oct 24, 2022
<乌鸦传媒>Do Crohn's Patients Do Better With Early Surgery? Danish study finds fewer reoperations, though higher risk for hospitalization Oct 20, 2022
<乌鸦传媒>Eating More Unprocessed Foods Tied to Lower Risk of Crohn's Disease No association seen for ulcerative colitis, however Oct 14, 2022
<乌鸦传媒>Some Environmental Pollutants Linked to IBS PM2.5, airborne toxic releases associated with zip code-level IBS incidence in California Oct 04, 2022
<乌鸦传媒>Higher Risk for Treatment Failure With Vedolizumab in Older IBD Patients Particularly for Crohn's disease, according to comparative effectiveness study Sep 30, 2022
<乌鸦传媒>Have We Been Overcautious With TNF Inhibitors in Pregnancy? Study of IBD patients finds no basis for common practice Sep 26, 2022
<乌鸦传媒>Noninvasive Gastric Mapping; Best Foods for the Gut? Lab Score for Crohn's News and commentary from the world of gastroenterology and hepatology Sep 22, 2022
<乌鸦传媒>IV Iron Replacements Go Head-to-Head for IBD-Related Anemia Trial confirms higher rate of hypophosphatemia with ferric carboxymaltose Sep 16, 2022
<乌鸦传媒>Ryan Reynolds' Colonoscopy; NASH Drug Passes Phase II Test; New Drug Target in IBD? News and commentary from the world of gastroenterology and hepatology Sep 14, 2022
<乌鸦传媒>New Drug for Gastric Ulcers; Linzess for Kids' Constipation; IBD Meds Safe in Utero News and commentary from the world of gastroenterology and hepatology Sep 08, 2022
<乌鸦传媒>First-in-Class Drug Brings Relief in Ulcerative Colitis Multiple doses of obefazimod bested placebo in randomized trial Sep 07, 2022
<乌鸦传媒>Complete Endoscopic Healing in IBD Linked to Lower Relapse Risk Though about a third of these patients still relapsed after cessation of TNF inhibitors Sep 02, 2022
<乌鸦传媒>MMR Vaccination Tied to Lower IBD Risk for Kids Parents hesitant to vaccinate should be reassured, study authors say Aug 24, 2022
<乌鸦传媒>Low Risk for IBD Relapse After Switch From IV to Subcutaneous Infliximab French study showed low relapse rates across all intravenous dose regimens, except for one Aug 19, 2022
<乌鸦传媒>C-Section Babies Face Higher Crohn's Disease Risk Later in Life Underlying mechanism could be the gut microbiome, researcher hypothesizes Aug 17, 2022
<乌鸦传媒>What's the Best New Drug for Luminal Crohn's Disease? Meta-analysis ranks infliximab and others, but experts urge results are not ready for prime time Aug 04, 2022
<乌鸦传媒>More Bad Safety News for Xeljanz Yet another risk confirmed in postmarketing study Aug 04, 2022
<乌鸦传媒>Medical Trauma in Patients With IBD Hospitalizations, flares, and pain cited as sources of post-traumatic stress Aug 01, 2022
